Clinical Trials Logo

Hyperlipidemia clinical trials

View clinical trials related to Hyperlipidemia.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06422650 Recruiting - Hyperlipidemia Clinical Trials

Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia

Start date: August 24, 2023
Phase: Phase 2
Study type: Interventional

This study will be 8 weeks randomized, double-blind, placebo-controlled trail to assess the effect of Nigella Sativa in 84 Hyperlipidaemic patients. Participants will be assessed at baseline and after 8 weeks of intervention. Subjects will be randomized to receive either Nigella Sativa 500 mg capsule daily or placebo capsule identical to Nigella Sativa twice daily for 8 weeks. Evaluation of lipid profile, SGPT, S.Creatinine will be before and after 8 weeks of intervention. Nigella Sativa related adverse events will be identified. Study outcome will establish safety and efficacy of Nigella Sativa in atorvastatin treated hyperlipidaemic patients

NCT ID: NCT06166121 Recruiting - Hyperlipidemia Clinical Trials

Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules

Start date: September 20, 2023
Phase: N/A
Study type: Interventional

This study focuses on PWV as the main outcome, aiming to evaluate the efficacy and safety of ShenJu in treating patients with hyperlipidemia combined with carotid atherosclerosis, and provide a basis for traditional Chinese medicine treatment of hyperlipidemia combined with carotid atherosclerosis.

NCT ID: NCT06041165 Recruiting - Hyperlipidemia Clinical Trials

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401

Start date: August 31, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetcs and pharmacodynamics of single-dose of JS401 in healthy volunteers with normal or mildly elevated triglycerides.

NCT ID: NCT06022575 Recruiting - Hyperlipidemia Clinical Trials

Telehealth Integrated Care Model in Patients With Cardiometabolic Disease

Start date: June 20, 2023
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to evaluate the telehealth integrated care model for its clinical efficacy, medical resource utilization, health economics measurement, and satisfaction survey indicators in hyperlipidemia patients and other cardiometabolic diseases. The result of the study will provide evidence for the value of integrated model in the treatment of patients with cardiometabolic syndrome.

NCT ID: NCT05990595 Recruiting - Type 2 Diabetes Clinical Trials

Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control

ADL
Start date: July 7, 2023
Phase: N/A
Study type: Interventional

This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and hyperglycemia. Through two weeks of cooked adlay-rice and white rice by a randomized cross-over design to evaluate the lipid- and glucose-lowering effects of adlay on patient with hyperlipidemia and/or hyperglycemia.

NCT ID: NCT05548933 Recruiting - Hyperlipidemia Clinical Trials

Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia

Start date: September 20, 2022
Phase:
Study type: Observational

This study was a single-center, non-randomized, parallel-group design clinical trial, and each group was assigned a 1:1 ratio with or without hyperlipidemia. Both groups underwent periodontal non-surgical treatment, and blood and gingival crevicular fluid were collected before surgery, 1 month and 3 months after surgery for the detection of MCP-1, IL-8, oxLDL, TNF-α, TG, LDL-C, HDL-C.

NCT ID: NCT05260411 Recruiting - Hyperlipidemia Clinical Trials

A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

Start date: January 26, 2022
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase # clinical study evaluating the efficacy and safety of AK102 Q6W in patients with primary hypercholesterolemia and mixed hyperlipidemia.

NCT ID: NCT05255458 Recruiting - Hyperlipidemia Clinical Trials

A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Start date: November 4, 2021
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase 3 clinical study evaluating the long-term efficacy and safety of AK102 in patients with primary hypercholesterolemia and mixed hyperlipidemia.

NCT ID: NCT05255094 Recruiting - Hyperlipidemia Clinical Trials

A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Start date: November 3, 2021
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase Ⅲ clinical study evaluating the efficacy and safety of AK102 in patients with primary hypercholesterolemia and mixed hyperlipidemia.

NCT ID: NCT04998981 Recruiting - Hyperlipidemia Clinical Trials

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Start date: September 17, 2021
Phase: Phase 3
Study type: Interventional

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients with High TG and Low HDL-C